Showing results (251-260 of 390) with videos related to

Sort By:
Pageof 39
Cancer Immunology, Immunotherapy : CII|November 11, 2018
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinomaCharlotte M Huijts, Inge M Werter, Sinéad M Lougheed, et al.
Neoplasia (New York, N.Y.)|April 15, 2014
Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragmentsGursah Kats-Ugurlu, Egbert Oosterwijk, Stijn Muselaers, et al.
BMC Cancer|September 20, 2024
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocolJetty A M Weijers, Gerald W Verhaegh, G Lassche, et al.
Acta Oncologica (Stockholm, Sweden)|October 4, 2018
Caregivers of patients receiving long-term treatment with a tyrosine kinase inhibitor (TKI) for gastrointestinal stromal tumour (GIST): a cross-sectional assessment of their distress and burdenS M C H Langenberg, A K L Reyners, A N M Wymenga, et al.
Heart Rhythm|March 8, 2007
Recommendations for the standardization and interpretation of the electrocardiogram. Part I: The electrocardiogram and its technology. A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm SocietyPaul Kligfield, Leonard S Gettes, James J Bailey, et al.
Head & Neck|January 7, 2020
Methotrexate plus or minus cetuximab as first-line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib-randomized phase II study CommenceJanneke C Ham, Esther van Meerten, W Edward Fiets, et al.
The Oncologist|December 9, 2020
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic CancerEmilie M J van Brummelen, Sanne Huijberts, Carla van Herpen, et al.
Head & Neck|April 6, 2013
Nutritional status, food intake, and dysphagia in long-term survivors with head and neck cancer treated with chemoradiotherapy: a cross-sectional studyManon G A van den Berg, Heidi Rütten, Ellen L Rasmussen-Conrad, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2010
Phase I evaluation of cediranib, a selective VEGFR signalling inhibitor, in combination with gefitinib in patients with advanced tumoursHester van Cruijsen, Emile E Voest, Cornelis J A Punt, et al.
Anticancer Research|May 5, 2005
Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1Carla M L van Herpen, Johan Bussink, Albert J van der Kogel, et al.
Pageof 39